Skip to main content

Table 1 Baseline characteristics of total cohort and by overall mortality

From: Fifteen-year experience with pericardiectomy at a tertiary referral center

 

Total

(n = 63)

Alive

(n = 47)

Dead

(n = 16)

p-value

Age, years

55.62 ± 14.27

54.79 ± 14.51

58.06 ± 13.69

0.6525

Body Mass Index

31.23 ± 8.31

32.3 ± 8.46

28.08 ± 7.21

0.0511

Gender

   

0.961

 Male

43 (68.25)

32 (68.09)

11 (68.75)

 

 Female

20 (31.75)

15 (31.91)

5 (31.25)

 

Race

   

0.681

 White

54 (85.71)

41 (87.23)

13 (81.25)

 

 Non-White

9 (14.29)

6 (12.77)

3 (18.75)

 

Risk Factors

 Congestive Heart Failure

57 (90.48)

42 (89.36)

15 (93.75)

> 0.999

 Prior Cardiac Intervention

29 (46.03)

18 (38.30)

11 (68.75)

0.035

 Prior Radiation Exposure

6 (9.52)

3 (6.38)

3 (18.75)

0.166

 Hypertension

50 (79.37)

36 (76.60)

14 (87.50)

0.486

 Liver Disease

15 (23.81)

12 (25.53)

3 (18.75)

0.740

 COPDa

16 (25.40)

11 (23.40)

5 (31.25)

0.533

 Pneumonia

15 (23.81)

12 (25.53)

3 (18.75)

0.740

 Diabetes

19 (30.16)

14 (29.79)

5 (31.25)

0.912

 Dyslipidemia

35 (55.56)

26 (55.32)

9 (56.25)

0.948

 CKDb - Dialysis

10 (15.87)

4 (8.51)

6 (37.50)

0.013

 CKDb - No Dialysis

11 (17.46)

9 (19.15)

2 (12.50)

0.714

 Coronary Artery Disease

21 (33.33)

15 (31.91)

6 (37.50)

0.682

 Atrial Fibrillation

19 (30.16)

15 (31.91)

4 (25.00)

0.757

 Hypothyroidism

13 (20.63)

11 (23.40)

2 (12.50)

0.486

 Prior Kidney Transplant

3 (4.76)

2 (4.26)

1 (6.25)

> 0.999

 Autoimmune Disease

8 (12.70)

6 (12.77)

2 (12.50)

> 0.999

 Illicit Drug Use

8 (12.70)

7 (14.89)

1 (6.25)

0.667

 Immunocompromised

10 (15.87)

5 (10.64)

5 (31.25)

0.051

 Pericardial Effusion

34 (53.97)

24 (51.06)

10 (62.50)

0.428

 Prior Pericardiocentesis

11 (17.46)

8 (17.02)

3 (18.75)

> 0.999

 Prior Pericardial Window

11 (17.46)

7 (14.89)

4 (25.00)

0.448

 Pleural Effusion

23 (36.51)

14 (29.79)

9 (56.25)

0.058

 Redo Sternotomy

9 (14.29)

4 (8.51)

5 (31.25)

0.039

 LVEFc

54.48 ± 10.70

54.53 ± 10.06

54.31 ± 12.97

0.8792

Reason for Surgery

   

0.217

 Constrictive Pericarditis

50 (79.37)

36 (76.60)

14 (87.50)

 

 Hemorrhagic Pericarditis

6 (9.52)

6 (12.77)

0

 

 Recurrent Pericardial Effusion

4 (6.35)

2 (4.26)

2 (12.50)

 

 Pyopericardium

3 (4.76)

3 (6.38)

0

 

NYHAd Class on Admission

   

0.386

 I

6 (9.52)

6 (12.77)

0

 

 II

21 (33.33)

16 (34.04)

5 (33.33)

 

 III

27 (42.86)

20 (42.55)

7 (46.67)

 

 IV

7 (11.11)

4 (8.51)

3 (20.00)

 

 Not Available

2 (3.17)

1 (2.13)

1 (6.25)

 

Presenting Symptoms

 Fever

5 (7.94)

4 (8.51)

1 (6.25)

> 0.999

 Nausea

5 (7.94)

5 (10.64)

0

0.317

 Dyspnea

57 (90.48)

41 (87.23)

16 (100.00)

0.324

 Fatigue

55 (87.30)

40 (85.11)

15 (93.75)

0.667

 Lower Extremity Edema

36 (57.14)

26 (55.32)

10 (62.50)

0.616

 Chest Pain

31 (49.21)

23 (48.94)

8 (50.00)

0.941

 Abdominal Distension

30 (47.62)

22 (46.81)

8 (50.00)

0.825

 Creatinine, mg/dL

1.09 (0.66)

1.01 (0.61)

1.5 (1.21)

0.0067

Medical Management

 Diuretics

41 (65.08)

32 (68.09)

9 (56.25)

0.391

 NSAIDe

23 (36.51)

19 (40.43)

4 (25.00)

0.371

 Colchicine

5 (7.94)

5 (10.64)

0

0.317

Intraop Variables

 Procedure Performed

   

0.222

  Isolated Pericardiectomy

42 (66.67)

29 (61.70)

13 (81.25)

 

  Pericardectomy + Concomitant Procedure

21 (33.33)

18 (38.30)

3 (18.75)

 

CPBf utilization

23 (36.51)

20 (42.55)

3 (18.75)

0.133

CPB time, minutes

162 ± 89.96

153.28 ± 88.99

214.33 ± 93.93

0.247

Cross Clamp time, minutes

110.43 ± 82.55

107.5 ± 81.70

128 ± 120.21

> 0.999

 Status

   

0.038

  Elective

41 (65.08)

34 (72.34)

7 (43.75)

 

  Urgent

22 (34.92)

13 (27.66)

9 (56.25)

 
  1. Values are expressed as n(%) and mean + standard deviation unless otherwise noted
  2. achronic obstructive pulmonary disease
  3. bchronic kidney disease
  4. cleft ventricular ejection fraction
  5. dNew York Heart Association
  6. enon-steroidal anti-inflammatory drug
  7. fcardiopulmonary bypass